All Stories

  1. The Prime and Integral Cause of Cancer in the Post-Warburg Era

    Article • Cancers, January 2023, MDPI AG

    Salvador Harguindey

  2. Hydrogen Ion Dynamics as the Fundamental Link between Neurodegenerative Diseases and Cancer: Its Application to the Therapeutics of Neurodegenerative Diseases with Special Emphasis on Multiple Sclerosis

    Article • International Journal of Molecular Sciences, February 2022, MDPI AG

    Salvador Harguindey

  3. Hydrogen Ion Dynamics as the Fundamental Link Between Neurodegenerative Diseases and Cancer. Its Application to the Therapeutics of Neurodegenerative Diseases with Special Emphasis in Multiple Sclerosis

    Article • February 2022, MDPI AG

    Salvador Harguindey

  4. Towards an Integral Therapeutic Protocol for Breast Cancer Based upon the New H+-Centered Anticancer Paradigm of the Late Post-Warburg Era

    Article • International Journal of Molecular Sciences, October 2020, MDPI AG

    Salvador Harguindey

  5. The Pentose Phosphate Pathway Dynamics in Cancer and Its Dependency on Intracellular pH

    Article • Metabolites, July 2020, MDPI AG

    Salvador Harguindey

  6. The Interplay of Dysregulated pH and Electrolyte Imbalance in Cancer

    Article • Cancers, April 2020, MDPI AG

    Salvador Harguindey

  7. A New and Integral Approach to the Etiopathogenesis and Treatment of Breast Cancer Based upon Its Hydrogen Ion Dynamics

    Article • International Journal of Molecular Sciences, February 2020, MDPI AG

    Salvador Harguindey

  8. Hydrogen Ion Dynamics of Cancer and a New Molecular, Biochemical and Metabolic Approach to the Etiopathogenesis and Treatment of Brain Malignancies

    Article • International Journal of Molecular Sciences, September 2019, MDPI AG

    Salvador Harguindey

  9. An integral approach to the etiopathogenesis of human neurodegenerative diseases (HNDDs) and cancer. Possible therapeutic consequences within the frame of the trophic factor withdrawal syndrome (TFWS)

    Article • Neuropsychiatric Disease and Treatment, October 2008, Dove Medical Press

    Salvador Harguindey